Engineering of a rough auxotrophic mutant Salmonella Typhimurium for effective delivery.

scientific article published on 22 May 2018

Engineering of a rough auxotrophic mutant Salmonella Typhimurium for effective delivery. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.25192
P932PMC publication ID5986645
P698PubMed publication ID29876000

P50authorJohn Hwa LeeQ90115270
Jonathan LalsiamtharaQ115075473
P2093author name stringJe Hyoung Kim
P2860cites workOne-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR productsQ27860842
Use of live bacterial vaccine vectors for antigen delivery: potential and limitationsQ31887727
Salmonella serosurveillance: different statistical methods to categorise pig herds based on serological dataQ33416275
Changes of physiological and biochemical properties of Salmonella enterica serovar Typhimurium by deletion of cpxR and lon genes using allelic exchange methodQ33510831
Statistical measurement of virulence and of immunity: application to the study of typhoid bacteria and to the measurement of immunizing power of antityphoid vaccinesQ41037214
Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.Q41337848
Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar TyphimuriumQ44381786
Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigensQ45764942
Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of miceQ47872108
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malariaQ47910752
Immuno-profiles of BALB/c mice inoculated with Salmonella vector delivering B-cell mitogen hydroxyproline epimeraseQ49923998
Derepression of Salmonella pathogenicity island 1 genes within macrophages leads to rapid apoptosis via caspase-1- and caspase-3-dependent pathwaysQ50094367
Salmonella vaccine carrier strains: effective delivery system to trigger anti-tumor immunity by oral routeQ50127302
Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strainQ50135609
Heterologous expression of the cuticular-glutathione peroxidase of lymphatic filariae in an attenuated vaccine strain of Salmonella typhimurium abrogates H-2 restriction of specific antibody responsesQ50138714
Virulence and vaccine potential of phoP mutants of Salmonella typhimuriumQ50195223
Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in miceQ68367993
Statistical procedures for calculating the residual virulence of Brucella abortus strain 19 (S19) and Brucella melitensis strain Rev 1 vaccines in mice: theoretical basis and practical applicationsQ79746204
Controlling the maturation of pathogen-containing vacuoles: a matter of life and deathQ33772671
Physiology, pathogenicity and immunogenicity of lon and/or cpxR deleted mutants of Salmonella Gallinarum as vaccine candidates for fowl typhoidQ33920959
Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutininQ34004542
Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigsQ34171892
Development of a multiplex PCR technique for detection and epidemiological typing of salmonella in human clinical samplesQ34311887
Mucosal immunity and vaccinesQ34409172
Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteriaQ34469773
Impact of vector priming on the immunogenicity of recombinant Salmonella vaccinesQ34531946
Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidateQ34738751
Oral immunization with an rfaH mutant elicits protection against salmonellosis in miceQ34760019
Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunityQ35130248
Targeting tumors with salmonella Typhimurium- potential for therapyQ35169604
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shockQ35176262
Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimuriumQ35273125
Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosisQ35406291
Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in miceQ35553171
Enteric pathogens as vaccine vectors for foreign antigen deliveryQ35896020
The role of host cell death in Salmonella infections.Q36080758
Comparison between Immunization Routes of Live Attenuated Salmonella Typhimurium Strains Expressing BCSP31, Omp3b, and SOD of Brucella abortus in Murine ModelQ36814216
A live attenuated Salmonella Enteritidis secreting detoxified heat labile toxin enhances mucosal immunity and confers protection against wild-type challenge in chickens.Q36969236
Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenicQ37009163
LAMP-3 (Lysosome-Associated Membrane Protein 3) Promotes the Intracellular Proliferation of Salmonella typhimuriumQ37121875
Engineering Salmonella as intracellular factory for effective killing of tumour cells.Q37134828
Virulence Associated Genes-Deleted Salmonella Montevideo Is Attenuated, Highly Immunogenic and Confers Protection against Virulent Challenge in ChickensQ37333735
An intermediate step in translocation of lipopolysaccharide to the outer membrane of Salmonella typhimuriumQ37604596
Pathogenic traits of Salmonella Montevideo in experimental infections in vivo and in vitroQ37741324
Pre-existing immunity against vaccine vectors--friend or foe?Q38061876
Engineered bacteria as therapeutic agentsQ38526395
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesQ39513114
The common mucosal immune system and current strategies for induction of immune responses in external secretionsQ39663021
Role of Salmonella enterica lipopolysaccharide in activation of dendritic cell functions and bacterial containmentQ39822002
Pathogenicity and protective effect of rough mutants of Salmonella species in germ-free piglets.Q39831824
Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimuriumQ40150964
Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challengeQ40169281
Phagolysosome Formation, Cyclic Adenosine 3':5'-Monophosphate and the Fate of Salmonella typhimurium within Mouse Peritoneal MacrophagesQ40225458
Evaluation of safety and protection efficacy on cpxR and lon deleted mutant of Salmonella Gallinarum as a live vaccine candidate for fowl typhoidQ40342233
P433issue39
P407language of work or nameEnglishQ1860
P921main subjectSalmonella TyphimuriumQ166491
P304page(s)25441-25457
P577publication date2018-05-22
P1433published inOncotargetQ1573155
P1476titleEngineering of a rough auxotrophic mutant Salmonella Typhimurium for effective delivery.
P478volume9

Reverse relations

cites work (P2860)
Q92886267Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge
Q91129598Partial protection induced by Salmonella based Brucella vaccine candidate in pregnant guinea pigs

Search more.